A randomized, double-blind, placebo-controlled trial of eszopiclone for the treatment of insomnia in patients with chronic low back pain.

ABSTRACT:

Study objectives

Insomnia, which is very common in patients with chronic low back pain (LBP), has long been viewed as a pain symptom that did not merit specific treatment. Recent data suggest that adding insomnia therapy to pain-targeted treatment should improve outcome; however, this has not been empirically tested in LBP or in any pain condition treated with a standardized pain medication regimen. We sought to test the hypothesis that adding insomnia therapy to pain-targeted treatment might improve sleep and pain in LBP.

Design

Double-blind, placebo-controlled, parallel-group, 1-mo trial.

Setting

Duke University Medical Center Outpatient Sleep Clinic.

Patients

Fifty-two adult volunteers with LBP of at least 3 mo duration who met diagnostic criteria for insomn

SUBMITTER: Goforth HW 

PROVIDER: S-EPMC4015379 | biostudies-literature | 2014 Jun

REPOSITORIES: biostudies-literature